Form 4: Pacira Biosciences COO Acquires Additional Shares Through Employee Stock Purchase Plan

The Chief Operating Officer of Pacira BioSciences, Inc. has increased their holdings in the company by acquiring additional shares through the employee stock purchase plan.

Summary

• Daryl Gaugler, Chief Operating Officer of Pacira BioSciences, Inc., acquired 243.537 shares of common stock.
• The shares were acquired under the company's employee stock purchase plan in December 2024.
• The purchase price was $16.014 per share.
• Following this transaction, Gaugler directly owns 115,443.489 shares of Pacira BioSciences.

Sentiment

Score: 5

Explanation: The document is neutral, reporting a standard transaction without any indication of positive or negative sentiment.

Positives

• The COO's purchase could be seen as a sign of confidence in the company's future prospects.
• Employee stock purchase plans can align employee interests with those of shareholders.

Negatives

• The number of shares acquired is relatively small compared to the COO's total holdings.

Risks

• The document does not provide a complete picture of the company's financial health or future prospects.
• The COO's purchase may not necessarily indicate positive future performance for the company.

Future Outlook

The document does not provide any explicit forward-looking statements.

Industry Context

This announcement is specific to Pacira BioSciences and does not directly relate to broader industry trends or competitors.

Comparison to Industry Standards

• This is a standard Form 4 filing for an insider transaction, common across all publicly traded companies.
• The purchase price of $16.014 per share is specific to this transaction and does not have a direct comparison to industry standards without knowing the fair market value of the stock at the time of purchase.
• The employee stock purchase plan is a common benefit offered by many companies, and the terms of such plans can vary widely.

Stakeholder Impact

• The impact on stakeholders is minimal as this is a routine transaction.
• Shareholders might view the COO's purchase as a minor positive signal.

Key Dates

Keywords

Pacira BioSciences, PCRX, Daryl Gaugler, Chief Operating Officer, employee stock purchase plan, insider trading, stock acquisition, SEC Form 4, beneficial ownership